Alignment Healthcare, Inc.
NASDAQ:ALHCMedical - Healthcare Plans
+$0.48 today
- Market cap
- $1.33B
- Beta
- 1.15
- P/E (TTM)
- 227.0
- EPS (TTM)
- $0.10
Volume 5.00M
Average 5.33M
Returns on capital
Alignment Healthcare, Inc. management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
ROE
-0.4%
avg -52.5%
ROIC
2.5%
avg -25.7%
ROA
-0.1%
avg -18.0%
Analysis
ROIC is currently the strongest return metric at 2.5% versus its period average of -25.7%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
John E. Kao | Founder, Chairman & CEO | USD 2.78M | 64 | 590.77K | 0.29% |
Dawn Christine Maroney | President | USD 1.74M | 58 | 794.61K | 0.38% |
Hyong J. Kim | Chief Medical Officer | USD 1.33M | 56 | — | — |
Christopher J. Joyce | Chief Legal & Administrative Officer | USD 1.3M | 62 | 305.45K | 0.15% |
James Head | Chief Financial Officer | USD 1.03M | 60 | — | — |
Andreas Wagner | Chief Human Resources Officer | USD 850.16K | 56 | — | — |
Joseph Samuel Konowiecki | Vice Chairman & Executive VP of Corporate Affairs | USD 100K | 72 | — | — |
Shane Hochradel | Chief Operations Officer | — | — | — | — |
Donald S. Furman | Co-Founder & Chief Clinical Officer | — | 75 | — | — |
Rob Scavo | Chief Information Officer | — | 61 | — | — |
Compensation is shown in the reported currency; data updated Nov 7, 2026.
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Sep 14, 2026.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
1
$197,626.88
Sells
78
$517.66M
Net Transaction Value
−$517.46M
Net selling
Most Active
KAO JOHN E
26 transactions
Transactions sorted by date, descending.
| Type | |||
|---|---|---|---|
| Nov 10, 26Nov 10, 2026 | KONOWIECKI JOSEPH S Direct | Sell | $35.5K$35,496.00 |
| Oct 6, 26Oct 6, 2026 | Kim Hyong Direct | Sell | $269.6K$269,575.70 |
| Sep 17, 26Sep 17, 2026 | KONOWIECKI JOSEPH S Direct | Sell | $202.4K$202,429.71 |
| Sep 14, 26Sep 14, 2026 | KAO JOHN E Indirect | Sell | $356.2K$356,200.00 |
| Sep 11, 26Sep 11, 2026 | KAO JOHN E Direct | Sell | $4.9M$4,885,223.60 |
| Sep 11, 26Sep 11, 2026 | Maroney Dawn Christine Direct | Sell | $1.6M$1,555,924.76 |
| Sep 10, 26Sep 10, 2026 | KAO JOHN E Indirect | Sell | $2.2M$2,236,447.24 |
| Aug 14, 26Aug 14, 2026 | Maroney Dawn Christine Direct | Sell | $70K$70,000.00 |
| Aug 10, 26Aug 10, 2026 | KAO JOHN E Indirect | Sell | $4.1M$4,136,776.40 |
| Jul 15, 26Jul 15, 2026 | Maroney Dawn Christine Direct | Sell | $3.7M$3,687,990.01 |
1–10 of 79
Summary
Insiders reported 1 buys worth $197,626.88 and 78 sells worth $517.66M over the last 12 months. That adds up to net selling of $517.46M. KAO JOHN E was the most active insider with 26 transactions.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A5 analysts |
| Revenue | N/A | N/A | +40.2% | +25.3% (5yr)5 analysts |
| Net Income | N/A | N/A | N/A | N/A5 analysts |
| EBIT | N/A | N/A | N/A | +88.0% (5yr)5 analysts |
Analysis
Recent growth has been strongest in Revenue at +40.2% over three years. Forward estimates point to EBIT at +88.0% (5yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Who does Alignment Healthcare, Inc. compete with?
Open similar companies to compare how their management teams allocate capital.
Competitors
Peer companies in the same sector
Questions
Management questions
Common questions about ALHC's management, answered from reported figures.
Who manages ALHC?
Alignment Healthcare, Inc. (ALHC) lists 10 active executives. The top listed executive is Shane Hochradel, Chief Operations Officer.
Are ALHC insiders buying or selling?
Recent insider activity shows net selling of $1.72B.
Continue the stock analysis
Jump to another research area for this company.